Multinational cooperation in trials and guidelines dealing with febrile neutropenia
Clicks: 294
ID: 119234
2000
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.6
/100
22 views
22 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Multinational cooperation has lead to many of the advances in the therapy of cancer patients with febrile neutropenia over the last two decades and will likely continue to do so. Some of the groups and societies that have contributed to this success include the European Organization for Research and …
| Reference Key |
r2000internationalmultinational
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Feld R;; |
| Journal | international journal of antimicrobial agents |
| Year | 2000 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
clinical trials as topic
humans
pubmed abstract
nih
national institutes of health
national library of medicine
immunocompromised host
neoplasms / complications*
neutropenia / complications*
practice guidelines as topic
anti-bacterial agents / therapeutic use*
fever / complications*
r feld
infections / drug therapy*
pmid:11053807
doi:10.1016/s0924-8579(00)00240-5
international cooperation*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.